These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

925 related articles for article (PubMed ID: 35199155)

  • 41. Genetic alterations in uterine fibroids - a new direction for pharmacological intervention?
    Markowski DN; Holzmann C; Bullerdiek J
    Expert Opin Ther Targets; 2015; 19(11):1485-94. PubMed ID: 26293838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Mediator Complex Subunit 12 (MED-12) Gene and Uterine Fibroids: a Systematic Review.
    Amendola ILS; Spann M; Segars J; Singh B
    Reprod Sci; 2024 Feb; 31(2):291-308. PubMed ID: 37516697
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and Cellular Insights into the Development of Uterine Fibroids.
    Machado-Lopez A; Simón C; Mas A
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445194
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proteomic Analysis Identifies Tenascin-C Expression Is Upregulated in Uterine Fibroids.
    Jamaluddin MFB; Nagendra PB; Nahar P; Oldmeadow C; Tanwar PS
    Reprod Sci; 2019 Apr; 26(4):476-486. PubMed ID: 29730954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma.
    Maekawa R; Yagi S; Ohgane J; Yamagata Y; Asada H; Tamura I; Sugino N; Shiota K
    J Reprod Dev; 2011 Oct; 57(5):604-12. PubMed ID: 21685710
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
    Karmon AE; Cardozo ER; Rueda BR; Styer AK
    Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas.
    Moridi I; Mamillapalli R; Kodaman PH; Habata S; Dang T; Taylor HS
    Reprod Sci; 2020 Sep; 27(9):1724-1730. PubMed ID: 32020550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The management of uterine fibroids in women with otherwise unexplained infertility.
    Carranza-Mamane B; Havelock J; Hemmings R; ;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):277-285. PubMed ID: 26001875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Estrogen-associated genes in uterine leiomyoma.
    Li S; McLachlan JA
    Ann N Y Acad Sci; 2001 Dec; 948():112-20. PubMed ID: 11795389
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden.
    Santulli P; Even M; Chouzenoux S; Millischer AE; Borghese B; de Ziegler D; Batteux F; Chapron C
    Hum Reprod; 2013 Aug; 28(8):2126-33. PubMed ID: 23739220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apoptosis in human uterine leiomyomas.
    Martel KM; Ko AC; Christman GM; Stribley JM
    Semin Reprod Med; 2004 May; 22(2):91-103. PubMed ID: 15164304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systematic analysis of gene expression pattern in has-miR-197 over-expressed human uterine leiomyoma cells.
    Ling J; Wu X; Fu Z; Tan J; Xu Q
    Biomed Pharmacother; 2015 Oct; 75():226-33. PubMed ID: 26311392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does aberrant DNA methylation occur in human uterine leiomyomas? An attempt of genome-wide screening by MS-RDA.
    Cai LY; Izumi S; Abe M; Imura M; Yasugi T; Wakazono K; Ohnuki Y; Kondo A; Ushijima T
    Tokai J Exp Clin Med; 2011 Sep; 36(3):84-90. PubMed ID: 21932190
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application.
    Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N
    Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The management of uterine leiomyomas.
    Lefebvre G; Vilos G; Allaire C; Jeffrey J; Arneja J; Birch C; Fortier M; Wagner MS;
    J Obstet Gynaecol Can; 2003 May; 25(5):396-418; quiz 419-22. PubMed ID: 12738981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent Advances in Uterine Fibroid Etiology.
    McWilliams MM; Chennathukuzhi VM
    Semin Reprod Med; 2017 Mar; 35(2):181-189. PubMed ID: 28278535
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular targets of dietary phytochemicals for possible prevention and therapy of uterine fibroids: Focus on fibrosis.
    Islam MS; Akhtar MM; Segars JH; Castellucci M; Ciarmela P
    Crit Rev Food Sci Nutr; 2017 Nov; 57(17):3583-3600. PubMed ID: 28609115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic basis of uterine leiomyoma: involvement of high mobility group protein genes.
    Van de Ven WJ
    Eur J Obstet Gynecol Reprod Biol; 1998 Dec; 81(2):289-93. PubMed ID: 9989879
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MED12 exon 2 mutations are common in uterine leiomyomas from South African patients.
    Mäkinen N; Heinonen HR; Moore S; Tomlinson IP; van der Spuy ZM; Aaltonen LA
    Oncotarget; 2011 Dec; 2(12):966-9. PubMed ID: 22182697
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Endocrine-disrupting chemicals and epigenetic reprogramming in developmental origin of uterine fibroids.
    Yang Q; Ali M; Bariani MV; Vafaei S; Al-Hendy A
    Sci Prog; 2023; 106(4):368504231215601. PubMed ID: 38189295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.